These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30456352)

  • 41. Contribution of putative efflux pump genes to isoniazid resistance in clinical isolates of
    Narang A; Giri A; Gupta S; Garima K; Bose M; Varma-Basil M
    Int J Mycobacteriol; 2017; 6(2):177-183. PubMed ID: 28559521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New lipophilic isoniazid derivatives and their 1,3,4-oxadiazole analogues: Synthesis, antimycobacterial activity and investigation of their mechanism of action.
    Vosátka R; Krátký M; Švarcová M; Janoušek J; Stolaříková J; Madacki J; Huszár S; Mikušová K; Korduláková J; Trejtnar F; Vinšová J
    Eur J Med Chem; 2018 May; 151():824-835. PubMed ID: 29679902
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Downregulation of katG expression is associated with isoniazid resistance in Mycobacterium tuberculosis.
    Ando H; Kitao T; Miyoshi-Akiyama T; Kato S; Mori T; Kirikae T
    Mol Microbiol; 2011 Mar; 79(6):1615-28. PubMed ID: 21244531
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular dynamics simulation studies of the wild-type, I21V, and I16T mutants of isoniazid-resistant Mycobacterium tuberculosis enoyl reductase (InhA) in complex with NADH: toward the understanding of NADH-InhA different affinities.
    Schroeder EK; Basso LA; Santos DS; de Souza ON
    Biophys J; 2005 Aug; 89(2):876-84. PubMed ID: 15908576
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of gallic acid formazans as novel enoyl acyl carrier protein reductase inhibitors for the treatment of tuberculosis.
    Saharan VD; Mahajan SS
    Bioorg Med Chem Lett; 2017 Feb; 27(4):808-815. PubMed ID: 28117201
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Significance of Coexisting Mutations on Determination of the Degree of Isoniazid Resistance in Mycobacterium tuberculosis Strains.
    Karunaratne GHRE; Wijesundera SS; Vidanagama D; Adikaram CP; Perera J
    Microb Drug Resist; 2018; 24(6):844-851. PubMed ID: 29683767
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
    Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
    J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular analysis of isoniazid resistance in different genotypes of Mycobacterium tuberculosis isolates from Iran.
    Doustdar F; Khosravi AD; Farnia P; Masjedi MR; Velayati AA
    Microb Drug Resist; 2008 Dec; 14(4):273-9. PubMed ID: 19090721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cross-docking study on InhA inhibitors: a combination of Autodock Vina and PM6-DH2 simulations to retrieve bio-active conformations.
    Stigliani JL; Bernardes-Génisson V; Bernadou J; Pratviel G
    Org Biomol Chem; 2012 Aug; 10(31):6341-9. PubMed ID: 22751934
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
    Wu X; Zhang J; Zhuang Y; Zhang X; Li G; He X
    Chin Med J (Engl); 1999 Jun; 112(6):524-8. PubMed ID: 11601331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of rpoB, katG and inhA gene mutations in Mycobacterium tuberculosis clinical isolates from Chongqing as determined by microarray.
    Yao C; Zhu T; Li Y; Zhang L; Zhang B; Huang J; Fu W
    Clin Microbiol Infect; 2010 Nov; 16(11):1639-43. PubMed ID: 20491829
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Unequal distribution of resistance-conferring mutations among Mycobacterium tuberculosis and Mycobacterium africanum strains from Ghana.
    Homolka S; Meyer CG; Hillemann D; Owusu-Dabo E; Adjei O; Horstmann RD; Browne EN; Chinbuah A; Osei I; Gyapong J; Kubica T; Ruesch-Gerdes S; Niemann S
    Int J Med Microbiol; 2010 Nov; 300(7):489-95. PubMed ID: 20538518
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug.
    Jena L; Waghmare P; Kashikar S; Kumar S; Harinath BC
    Int J Mycobacteriol; 2014 Dec; 3(4):276-82. PubMed ID: 26786627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of potential inhibitors of
    Kamera S; Sharma VK; Prasad V B; Garlapati A
    J Biomol Struct Dyn; 2023 Aug; ():1-15. PubMed ID: 37526169
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.
    Lu H; Tonge PJ
    Acc Chem Res; 2008 Jan; 41(1):11-20. PubMed ID: 18193820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity.
    Koçak Aslan E; Han Mİ; Krishna VS; Tamhaev R; Dengiz C; Doğan ŞD; Lherbet C; Mourey L; Tønjum T; Gündüz MG
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297413
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Genotypic analysis of isoniazid and rifampin resistance in drug-resistant clinical Mycobacterium tuberculosis complex isolates in southern Turkey.
    Aslan G; Tezcan S; Serin MS; Emekdas G
    Jpn J Infect Dis; 2008 Jul; 61(4):255-60. PubMed ID: 18653964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of isoniazid and rifampicin resistance by sequencing of katG, inhA, and rpoB genes in Korea.
    Cho EH; Bae HK; Kang SK; Lee EH
    Korean J Lab Med; 2009 Oct; 29(5):455-60. PubMed ID: 19893355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of novel and reported mutations in the rpoB, katG and inhA genes in multidrug-resistant tuberculosis isolates: A hospital-based study.
    Ramasubban G; Therese KL; Lakshmipathy D; Sridhar R; Meenakshi N; Madhavan HN
    J Glob Antimicrob Resist; 2015 Mar; 3(1):1-4. PubMed ID: 27873643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.